650 related articles for article (PubMed ID: 31270231)
1. A Single Amino Acid Substitution at Residue 218 of Hemagglutinin Improves the Growth of Influenza A(H7N9) Candidate Vaccine Viruses.
Li X; Gao Y; Ye Z
J Virol; 2019 Oct; 93(19):. PubMed ID: 31270231
[TBL] [Abstract][Full Text] [Related]
2. 220 mutation in the hemagglutinin of avian influenza A (H7N9) virus alters antigenicity during vaccine strain development.
Liu L; Lu J; Li Z; Zhou J; Guo J; Li X; Liu J; Shu Y; Wang D
Hum Vaccin Immunother; 2018 Mar; 14(3):532-539. PubMed ID: 29300686
[TBL] [Abstract][Full Text] [Related]
3. Development of influenza A(H7N9) candidate vaccine viruses with improved hemagglutinin antigen yield in eggs.
Ridenour C; Johnson A; Winne E; Hossain J; Mateu-Petit G; Balish A; Santana W; Kim T; Davis C; Cox NJ; Barr JR; Donis RO; Villanueva J; Williams TL; Chen LM
Influenza Other Respir Viruses; 2015 Sep; 9(5):263-70. PubMed ID: 25962412
[TBL] [Abstract][Full Text] [Related]
4. The effect of single amino acid substitution at position 220 in the hemagglutinin glycoprotein on avian influenza H7N9 candidate vaccine virus.
Liu L; Li Z; Zhou J; Lu J; Li X; Liu J; Xiao N; Wang D
Virus Genes; 2021 Apr; 57(2):164-171. PubMed ID: 33606171
[TBL] [Abstract][Full Text] [Related]
5. Development of high-growth influenza H7N9 prepandemic candidate vaccine viruses in suspension MDCK cells.
Tzeng TT; Chen PL; Weng TC; Tsai SY; Lai CC; Chou HI; Chen PW; Lu CC; Liu MT; Sung WC; Lee MS; Hu AY
J Biomed Sci; 2020 Apr; 27(1):47. PubMed ID: 32241276
[TBL] [Abstract][Full Text] [Related]
6. L226Q Mutation on Influenza H7N9 Virus Hemagglutinin Increases Receptor-Binding Avidity and Leads to Biased Antigenicity Evaluation.
Wang Y; Lv Y; Niu X; Dong J; Feng P; Li Q; Xu W; Li J; Li C; Li J; Luo J; Li Z; Liu Y; Tan YJ; Pan W; Chen L
J Virol; 2020 Sep; 94(20):. PubMed ID: 32796071
[TBL] [Abstract][Full Text] [Related]
7. Manipulation of neuraminidase packaging signals and hemagglutinin residues improves the growth of A/Anhui/1/2013 (H7N9) influenza vaccine virus yield in eggs.
Barman S; Krylov PS; Turner JC; Franks J; Webster RG; Husain M; Webby RJ
Vaccine; 2017 Mar; 35(10):1424-1430. PubMed ID: 28162820
[TBL] [Abstract][Full Text] [Related]
8. A Replication-Defective Influenza Virus Harboring H5 and H7 Hemagglutinins Provides Protection against H5N1 and H7N9 Infection in Mice.
Tian X; Landreth S; Lu Y; Pandey K; Zhou Y
J Virol; 2021 Jan; 95(3):. PubMed ID: 33177192
[TBL] [Abstract][Full Text] [Related]
9. Development of a high-yield live attenuated H7N9 influenza virus vaccine that provides protection against homologous and heterologous H7 wild-type viruses in ferrets.
Chen Z; Baz M; Lu J; Paskel M; Santos C; Subbarao K; Jin H; Matsuoka Y
J Virol; 2014 Jun; 88(12):7016-23. PubMed ID: 24719414
[TBL] [Abstract][Full Text] [Related]
10. Generation and Characterization of Live Attenuated Influenza A(H7N9) Candidate Vaccine Virus Based on Russian Donor of Attenuation.
Shcherbik S; Pearce N; Balish A; Jones J; Thor S; Davis CT; Pearce M; Tumpey T; Cureton D; Chen LM; Villanueva J; Bousse TL
PLoS One; 2015; 10(9):e0138951. PubMed ID: 26405798
[TBL] [Abstract][Full Text] [Related]
11. Development of a high-yield reassortant influenza vaccine virus derived from the A/Anhui/1/2013 (H7N9) strain.
Nakamura K; Shirakura M; Suzuki Y; Naito T; Fujisaki S; Tashiro M; Nobusawa E
Vaccine; 2016 Jan; 34(3):328-33. PubMed ID: 26657023
[TBL] [Abstract][Full Text] [Related]
12. A recombinant H7N9 influenza vaccine with the H7 hemagglutinin transmembrane domain replaced by the H3 domain induces increased cross-reactive antibodies and improved interclade protection in mice.
Wang Y; Wu J; Xue C; Wu Z; Lin Y; Wei Y; Wei X; Qin J; Zhang Y; Wen Z; Chen L; Liu GD; Cao Y
Antiviral Res; 2017 Jul; 143():97-105. PubMed ID: 28408133
[TBL] [Abstract][Full Text] [Related]
13. Identification of critical residues in the hemagglutinin and neuraminidase of influenza virus H1N1pdm for vaccine virus replication in embryonated chicken eggs.
Wang W; Lu J; Cotter CR; Wen K; Jin H; Chen Z
J Virol; 2013 Apr; 87(8):4642-9. PubMed ID: 23408613
[TBL] [Abstract][Full Text] [Related]
14. Immune Escape Adaptive Mutations in the H7N9 Avian Influenza Hemagglutinin Protein Increase Virus Replication Fitness and Decrease Pandemic Potential.
Chang P; Sealy JE; Sadeyen JR; Bhat S; Lukosaityte D; Sun Y; Iqbal M
J Virol; 2020 Sep; 94(19):. PubMed ID: 32699084
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of MDCK cell-derived influenza H7N9 vaccine candidates in ferrets.
Chia MY; Hu AY; Tseng YF; Weng TC; Lai CC; Lin JY; Chen PL; Wang YF; Chao SR; Chang JY; Hwang YS; Yeh CT; Yu CP; Chen YC; Su IJ; Lee MS
PLoS One; 2015; 10(3):e0120793. PubMed ID: 25799397
[TBL] [Abstract][Full Text] [Related]
16. Plant-derived H7 VLP vaccine elicits protective immune response against H7N9 influenza virus in mice and ferrets.
Pillet S; Racine T; Nfon C; Di Lenardo TZ; Babiuk S; Ward BJ; Kobinger GP; Landry N
Vaccine; 2015 Nov; 33(46):6282-9. PubMed ID: 26432915
[TBL] [Abstract][Full Text] [Related]
17. Development of a new candidate H5N1 avian influenza virus for pre-pandemic vaccine production.
Dong J; Matsuoka Y; Maines TR; Swayne DE; O'Neill E; Davis CT; Van-Hoven N; Balish A; Yu HJ; Katz JM; Klimov A; Cox N; Li DX; Wang Y; Guo YJ; Yang WZ; Donis RO; Shu YL
Influenza Other Respir Viruses; 2009 Nov; 3(6):287-95. PubMed ID: 19903211
[TBL] [Abstract][Full Text] [Related]
18. HA-Dependent Tropism of H5N1 and H7N9 Influenza Viruses to Human Endothelial Cells Is Determined by Reduced Stability of the HA, Which Allows the Virus To Cope with Inefficient Endosomal Acidification and Constitutively Expressed IFITM3.
Hensen L; Matrosovich T; Roth K; Klenk HD; Matrosovich M
J Virol; 2019 Dec; 94(1):. PubMed ID: 31597765
[TBL] [Abstract][Full Text] [Related]
19. Development of an Influenza A Master Virus for Generating High-Growth Reassortants for A/Anhui/1/2013(H7N9) Vaccine Production in Qualified MDCK Cells.
Suzuki Y; Odagiri T; Tashiro M; Nobusawa E
PLoS One; 2016; 11(7):e0160040. PubMed ID: 27454606
[TBL] [Abstract][Full Text] [Related]
20. Glycosylation generates an efficacious and immunogenic vaccine against H7N9 influenza virus.
Kim JI; Park S; Bae JY; Lee S; Kim J; Kim G; Yoo K; Heo J; Kim YS; Shin JS; Park MS; Park MS
PLoS Biol; 2020 Dec; 18(12):e3001024. PubMed ID: 33362243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
